Enlivex Therapeutics
ENLV
ENLV
15 hedge funds and large institutions have $2.16M invested in Enlivex Therapeutics in 2016 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$104K | |
| 2 | +$19K | |
| 3 | +$10K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$6.86K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$1.13K |
Top Sellers
| 1 | -$79.9K | |
| 2 | -$15.2K | |
| 3 | -$3.87K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$349 |